The Effect of Genetic Variation on Outcomes for Alcohol Dependence Treatment

Victor M. Karpyak, M.D., Ph.D., director of Mayo Clinic Addiction Services, discusses research on variation in the prodynorphin (PDYN) gene sequence and how it affects post-treatment relapse in subjects who are alcohol dependent.

Access Restricted

You must provide the password to continue.